PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FCL08
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $58,844
Award facts
- Contract value 100% obligated
- $58,843.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 14, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $58,843.78 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, which carries an ultimate completion date of January 15, 2026, was competitively awarded without set-aside designation. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to military healthcare programs worldwide through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio encompasses delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and antibiotics. The company's demonstrated capability to compete successfully on a full and open basis, combined with its extensive experience fulfilling DLA medical supply requirements, underscores its role as a key provider within the Defense Health Agency's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2D826FCL08?
SPE2D826FCL08 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 14, 2026.
How much is contract SPE2D826FCL08 worth?
The government has obligated $58,844 on SPE2D826FCL08.
Is contract SPE2D826FCL08 an order under another contract?
Yes. SPE2D826FCL08 is a delivery order under SPE2DX22D0019, an indefinite delivery contract.
Was contract SPE2D826FCL08 competed?
The extent of competition for SPE2D826FCL08 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award